High intensity focused ultrasound, or HIFU, is a minimally invasive treatment option for localized prostate cancer that may offer a balance between eliminating cancer and maintaining quality of life. HIFU with the Sonablate® 500 (Sonablate HIFU) is an out-patient, radiation-free procedure.
The HIFU procedure may be an option for men diagnosed with organ-confined prostate cancer. During the procedure, precisely focused ultrasound waves raise the temperature of the targeted prostate tissue to 195 degrees Fahrenheit in 2-3 seconds. This rapid-firing heat destroys the targeted tissue while leaving structures outside the targeted tissue unharmed.
Explore our website to understand more about prostate cancer and Sonablate HIFU.
The Sonablate® 500 is approved for investigational use only within the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S.
International HIFU’s treatment centers enable U.S. patients access to HIFU technology for prostate cancer in locations where it is available for use including Nassau, Bahamas; Cancun and Puerto Vallarta, Mexico; Bermuda; and Toronto, Niagara Falls, Montreal and Winnipeg, Canada.
thebahamasweekly.com, April 9, 2013
Washington, DC, October 14-17, 2012
Urology Times, May 1, 2012
National Institute for Health and Clinical Excellence (NICE), April 2012
My wife and I went to Cancun several days early and had a vacation prior to the procedure. Saturday arrived and we were picked up at the hotel that the HIFU folks had arranged for us, the Ritz Carlton. I arrived at the hospital at 10:30, was prepped, walked into the actual procedure room, lay on the table, and woke up!
